Market Context — Why This Technology, Why Now

The global bio-economy is rapidly expanding, driven by increasing consumer demand for sustainable, plant-derived products across food, medicine, and materials. Concurrently, industries face mounting pressure to optimize resource use and reduce environmental footprints. This technology offers a crucial pathway to meet these demands by enabling faster, more efficient, and cost-effective plant-based production, thereby accelerating innovation in sustainable agriculture, biopharmaceuticals, and advanced biomaterials.

Key Competitive Advantages
01

Enhances plant cell dedifferentiation and redifferentiation by suppressing SIZ1 gene expression, potentially reducing production costs by up to 30% compared to conventional tissue culture.

02

Offers high originality with only 3 prior art references, ensuring exclusive use until 2041 and establishing a long-term competitive edge in the biotechnology market.

03

Applicable to diverse plant species, not limited to specific types, with potential to develop high-value products and innovate production processes across food, pharmaceuticals, cosmetics, materials, and environmental remediation.

Market Opportunity
Food and Agriculture
~$3B globally (AI est.)
Accelerates the rapid development and mass production of high-performance crop varieties and enables applications in cellular agriculture, contributing to enhanced food production efficiency and stable supply.
Global agricultural biotechnology firms Seed and plant breeding companies Cellular agriculture startups
Pharmaceuticals and Cosmetics
~$2B globally (AI est.)
Supports the stable supply and cost reduction of plant-derived active ingredients for pharmaceuticals and cosmetics, leveraging plants as biofactories to drive market growth.
Biopharmaceutical companies Specialty chemical manufacturers Cosmetic ingredient suppliers
Materials and Biofuels
~$1.5B globally (AI est.)
Enables high-efficiency biomass production and the development of low-environmental-impact materials, fostering new material industries crucial for achieving a sustainable society.
Bio-based material developers Renewable energy companies Environmental remediation service providers
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a broad range of technical applications through 15 claims, specifically covering transformed plants or plant parts with enhanced dedifferentiation and redifferentiation capacity by suppressing SIZ1 gene expression or activity. Its robustness was established by overcoming three prior art references during examination, demonstrating strong novelty and inventiveness.

Competitive White Space

This patent focuses on SIZ1 gene suppression. White space exists in developing novel gene editing tools for other regeneration pathways, optimizing downstream processing of regenerated plant materials, or engineering specific plant varieties for enhanced compound synthesis.

Economic Impact
~$40K/year estimated cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Assuming a 20% reduction in plant cell culture to plant regeneration cycle time. For example, if annual culture and regeneration process costs are $200K (AI est.), the reduction in labor and equipment operating costs due to cycle time shortening is estimated at $40K/year (AI est.) ($200K × 20%). With increased yield and quality stabilization from improved regeneration efficiency, the total economic impact could exceed 30% annually.

Speed to Market
4× faster than in-house development
This technology's core mechanism, enhancing plant dedifferentiation and redifferentiation through SIZ1 gene manipulation, is already patented. Fundamental biological mechanism validation is complete. Focusing on integration and optimization with existing plant biotechnology facilities could significantly reduce the timeline compared to developing SIZ1 gene identification, modification, and evaluation from scratch, enabling rapid market entry for licensees.
Competitive Positioning

X: Technological Innovation
Y: Industrial Application Potential

Business Models & Applications
🤝 Licensing Model
A licensing model allowing companies to integrate this technology into their R&D or production processes. Licensing agreements tailored to specific plant species or product lines are envisioned.
🔬 Joint R&D Model
A collaborative R&D model to unlock new value from this technology through joint research focused on specific applications or plant species, aiming for co-commercialization. Partnership with national research institutes enhances technical credibility.
💡 Technology Consulting Model
A model providing specialized knowledge and know-how for the implementation and optimization of this technology, supporting licensees in solving their challenges. It offers effective utilization strategies alongside technology transfer.
Adjacent Application Opportunities
🌿 Smart Agriculture
High-Quality Seedling Rapid and Stable Production System
Applying this technology could enable rapid, large-scale propagation of superior plant varieties, ensuring a stable supply of seedlings with traits like disease resistance and high yield. This maximizes production efficiency in smart agriculture, accelerates market entry for high-value crops, and contributes to food security.
🧪 Biopharmaceuticals and Functional Foods
High-Efficiency Valuable Substance Production via Plant Bioreactors
Transformed plants could be utilized as bioreactors to efficiently produce pharmaceutical raw materials, vaccines, and functional proteins. Enhanced regeneration through SIZ1 suppression contributes to shorter production cycles and increased yields, boosting cost competitiveness and accelerating drug development.
♻️ Environmental Remediation and Biofuels
Rapid Cultivation of Low-Impact Biomass Feedstock
Enhancing the regeneration capacity of plants with high heavy metal absorption or CO2 sequestration capabilities could efficiently cultivate biomass feedstock for environmental remediation projects and biofuel production. This fosters new industries contributing to a sustainable society and offers concrete solutions to environmental challenges.
Integration Roadmap — Estimated 18-Month Deployment
Phase 1: Technology Evaluation and Application Planning
Duration: 3 months
Select target plant species, evaluate the applicability of SIZ1 suppression technology, analyze compatibility with existing research facilities, and conduct conceptual design.
Phase 2: Proof-of-Concept and Prototype Development
Duration: 9 months
Create SIZ1-suppressed transgenic plants in selected species and conduct proof-of-concept experiments for enhanced dedifferentiation and redifferentiation. Concurrently, develop and optimize prototypes for high-efficiency production processes.
Phase 3: Mass Production Preparation and Business Expansion
Duration: 6 months
Based on validation results, design production facilities for mass production, establish quality control systems, and formulate market entry strategies to ensure stable product supply and business growth.
Technical Feasibility
This technology is based on a clear molecular mechanism: suppressing or inhibiting the expression or activity of a specific gene (SIZ1). This offers high compatibility with existing genetic engineering techniques and plant tissue culture facilities, indicating low integration barriers. The patent claims suggest using standard biotechnology methods for gene introduction and expression suppression, making it highly feasible to integrate into existing research and production infrastructure without significant new capital investment.
Success Scenario
Implementing this technology could halve the plant regeneration period from tissue culture for specific plant species. This is expected to significantly accelerate new variety development cycles and expedite market entry. Furthermore, it could establish a stable supply system for plant cells producing valuable compounds, potentially doubling annual production without additional investment, thereby forming a basis for competitive advantage.
Patent Record
APPLICATION NO.
特願2021-054721
REGISTRATION NO.
7664605
FILING DATE
2021/03/29
GRANT DATE
2025/04/10
EXPIRATION DATE
2041/03/29
PATENT HOLDER
国立研究開発法人理化学研究所
Examination History
2024年02月09日
出願審査請求書
2025年01月07日
拒絶理由通知書
2025年02月14日
手続補正書（自発・内容）
2025年02月14日
意見書
2025年03月25日
特許査定